 |
|
Cognitive Impairment and the Brain Dopaminergic System in Parkinson Disease
[18F]Fluorodopa Positron Emission Tomographic Study
Juha O. Rinne, MD, PhD;
Raija Portin, PsychLic;
Hanna Ruottinen, MD;
Elina Nurmi, MD;
Jörgen Bergman, MSc;
Merja Haaparanta, MSc;
Olof Solin, PhD
Arch Neurol. 2000;57:470-475.
Objective To investigate the role of the brain dopaminergic system in cognitive impairment in patients with Parkinson disease (PD).
Design We studied 28 patients with PD and 16 age-matched healthy control subjects using [18F]fluorodopa (fluorodopa F 18) positron emission tomography. Patients with PD showed a variable degree of cognitive impairment, which was assessed using the Mini-Mental State Examination and detailed neuropsychologic assessment, including tests sensitive for frontal lobe function.
Results [18F]Fluorodopa uptake was reduced in the putamen (to 36% of the control mean; P<.001), the caudate nucleus (to 61% of the control mean; P<.001), and the frontal cortex (to 45% of the control mean; P<.001) in patients with PD compared with controls. There was no significant association between the degree of overall cognitive impairment of patients and [18F]fluorodopa uptake values. The influx constant (Kiocc) in the caudate nucleus had a negative association with performance in the attention-demanding Stroop interference task, especially with the interference time. The Kiocc in the frontal cortex had a positive correlation with performance in the digit span (backwards), verbal fluency, and verbal immediate recall tests. Thus, the better the patient performed in tasks demanding immediate and working memory and executive strategies, the better the [18F]fluorodopa uptake in the frontal cortex. In the putamen, no significant correlation was seen between the Kiocc value and any of the cognitive tests. The severity of the motor symptoms of PD and [18F]fluorodopa uptake showed a negative correlation in the putamen (r = -0.38; P = .04), and in the caudate nucleus a similar trend was seen (r = -0.36; P = .06).
Conclusions Reduced [18F]fluorodopa uptake in PD in the caudate nucleus (and frontal cortex) is related to impairment in neuropsychologic tests measuring verbal fluency, working memory, and attentional functioning reflecting frontal lobe function. This indicates that dysfunction of the dopamine system has an impact on the cognitive impairment of patients with PD. However, our results do not exclude the possibility of more generalized cognitive impairment in PD, the pathophysiology of which is probably different and more generalized.
From the Department of Neurology, University of Turku (Drs Rinne, Portin, Ruottinen, and Nurmi), and the Turku PET Centre, Radiopharmaceutical Chemistry and Accelerator Laboratory, Åbo Akademi University (Mr Bergman, Ms Haaparanta, and Dr Solin), Turku, Finland.
RELATED ARTICLE
Archives of Neurology Reader's Choice: Continuing Medical Education
Arch Neurol. 2000;57(4):613-614.
FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Temporal dynamics of basal ganglia under-recruitment in Parkinson's disease: transient caudate abnormalities during updating of working memory
Marklund et al.
Brain 2008;0:awn309v1-awn309.
ABSTRACT
| FULL TEXT
Current Management of the Cognitive Dysfunction in Parkinson's Disease: How Far Have We Come?
Vale
Exp. Biol. Med. 2008;233:941-951.
ABSTRACT
| FULL TEXT
Parkinson's disease and dopaminergic therapy--differential effects on movement, reward and cognition
Rowe et al.
Brain 2008;131:2094-2105.
ABSTRACT
| FULL TEXT
Striatal Dopamine and Working Memory
Landau et al.
Cereb Cortex 2008;0:bhn095v1-bhn095.
ABSTRACT
| FULL TEXT
Lateralisation of striatal function: evidence from 18F-dopa PET in Parkinson's disease
Cheesman et al.
J. Neurol. Neurosurg. Psychiatry 2005;76:1204-1210.
ABSTRACT
| FULL TEXT
Cognitive Dysfunction in Parkinson's Disease: The Role of Frontostriatal Circuitry
Owen
Neuroscientist 2004;10:525-537.
ABSTRACT
Fluctuations in cognition and alertness in Parkinson's disease and dementia
Serrano and Garcia-Borreguero
Neurology 2004;63:S31-S34.
ABSTRACT
| FULL TEXT
Enhancement of Working Memory in Aged Monkeys by a Sensitizing Regimen of Dopamine D1 Receptor Stimulation
Castner and Goldman-Rakic
J. Neurosci. 2004;24:1446-1450.
ABSTRACT
| FULL TEXT
Cognitive Impairments in Early Parkinson's Disease Are Accompanied by Reductions in Activity in Frontostriatal Neural Circuitry
Lewis et al.
J. Neurosci. 2003;23:6351-6356.
ABSTRACT
| FULL TEXT
Cognitive slowing in Parkinson's disease resolves after practice
Press et al.
J. Neurol. Neurosurg. Psychiatry 2002;73:524-528.
ABSTRACT
| FULL TEXT
Coffee Consumption and Cognitive Function among Older Adults
Johnson-Kozlow et al.
Am J Epidemiol 2002;156:842-850.
ABSTRACT
| FULL TEXT
Striatal and extrastriatal dysfunction in Parkinson's disease with dementia: a 6-[18F]fluoro-L-dopa PET study
Ito et al.
Brain 2002;125:1358-1365.
ABSTRACT
| FULL TEXT
Attention to action in Parkinson's disease: Impaired effective connectivity among frontal cortical regions
Rowe et al.
Brain 2002;125:276-289.
ABSTRACT
| FULL TEXT
Increased frontal [18F]fluorodopa uptake in early Parkinson's disease: sex differences in the prefrontal cortex
Kaasinen et al.
Brain 2001;124:1125-1130.
ABSTRACT
| FULL TEXT
Personality traits and brain dopaminergic function in Parkinson's disease
Kaasinen et al.
Proc. Natl. Acad. Sci. USA 2001;98:13272-13277.
ABSTRACT
| FULL TEXT
|
